Long COVID patients exhibit significant cognitive slowing, new study finds

Researchers find that patients with long COVID exhibit moderate-to-severe cognitive slowing compared to controls, highlighting a distinct cognitive signature of post-COVID-19 condition.

Newborn Screening for Duchenne Muscular Dystrophy

The X-linked neuromuscular disorder Duchenne muscular dystrophy (DMD), which historically has been diagnosed in boys between the ages of 3 and 6 years, has become

June 4, 2024

Pyroptosis: A potential therapeutic target for lung cancer

Lung cancer, one of the most aggressive forms of cancer, continues to be a leading cause of death worldwide. Although several new therapies have been

June 28, 2023

Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis – Biotech Investments

EQS-News: Imcyse SA / Key word(s): Miscellaneous Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.